Santhosh Palani - 12 Mar 2024 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
Director
Signature
/s/ Pamela Connealy, Attorney-in-Fact for Santhosh Palani
Issuer symbol
PYXS
Transactions as of
12 Mar 2024
Net transactions value
$0
Form type
4
Filing time
13 Mar 2024, 16:54:35 UTC
Previous filing
06 Mar 2024
Next filing
07 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PYXS Stock Option (Right to Buy) Award $0 +69,760 $0.000000 69,760 12 Mar 2024 Common Stock 69,760 $5.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest in three equal annual installments beginning on the first anniversary of March 12, 2024, subject to the reporting person's continued service through the applicable vesting date.